An EANM position paper on advancing radiobiology for shaping the future of nuclear medicine

Jean-Pierre Pouget*, Mark Konijnenberg, EANM Radiobiol Working Grp, Uta Eberlein, Gerhard Glatting, Pablo Minguez Gabina, Ken Herrmann, Soren Holm, Lidia Strigari, Fijs W. B. van Leeuwen, Michael Lassmann

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

11 Citations (Scopus)
15 Downloads (Pure)
Original languageEnglish
Pages (from-to)242-246
Number of pages5
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume50
Issue number2
Early online date6 Sept 2022
DOIs
Publication statusPublished - Jan 2023

Bibliographical note

Funding Information:
K.H. reports personal fees from Bayer, personal fees and other from Sofie Biosciences, personal fees from SIRTEX, non-financial support from ABX, personal fees from Adacap, personal fees from Curium, personal fees from Endocyte, grants and personal fees from BTG, personal fees from IPSEN, personal fees from Siemens Healthineers, personal fees from GE Healthcare, personal fees from Amgen, personal fees from Novartis, personal fees from ymabs, personal fees from Aktis Oncology, personal fees from Theragnostics, personal fees from Pharma15, personal fees from Debiopharm, personal fees from AstraZeneca, personal and fees from Janssen, outside the submitted work.

Cite this